These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4643457)

  • 1. Operant behavior and catecholamine-containing neurons: prolonged increase in lever-pressing after 6-hydroxydopamine.
    Schoenfeld RI; Uretsky NJ
    Eur J Pharmacol; 1972 Dec; 20(3):357-62. PubMed ID: 4643457
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of alpha-methyltyrosine on operant behavior and brain catecholamine levels.
    Schoenfeld RI; Seiden LS
    J Pharmacol Exp Ther; 1969 Jun; 167(2):319-27. PubMed ID: 5787869
    [No Abstract]   [Full Text] [Related]  

  • 3. Alpha-methyltyrosine: effects on fixed ratio schedules of reinforcement.
    Schoenfeld R; Seiden LS
    J Pharm Pharmacol; 1967 Nov; 19(11):771-2. PubMed ID: 4383702
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 5. Catecholamines and operant response rates in albino rats.
    Will B; Maurissen J; Ropartz P
    Psychopharmacol Commun; 1976; 2(3):219-29. PubMed ID: 996277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.
    Corrodi H; Fuxe K; Hökfelt T; Lidbrink P; Ungerstedt U
    J Pharm Pharmacol; 1973 May; 25(5):409-12. PubMed ID: 4146398
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of intracisternal 6-hydroxydopamine treatment on acquisition and performance of rats in a double T-maze.
    Howard JL; Grant LD; Breese GR
    J Comp Physiol Psychol; 1974 Jun; 86(6):995-1007. PubMed ID: 4836849
    [No Abstract]   [Full Text] [Related]  

  • 8. DRL performance in 6-hydroxydopamine-treated rats.
    Levine TE; McGuire PS; Heffner TG; Seiden LS
    Pharmacol Biochem Behav; 1980 Feb; 12(2):287-91. PubMed ID: 7375491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adaptation to the behavioral effects of 6-hydroxydopamine].
    Semenova TP; Tret'iak TM; Grishchenko NI; Smirnova GN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1983; 33(1):163-5. PubMed ID: 6404069
    [No Abstract]   [Full Text] [Related]  

  • 10. Catecholamines and drug-behavior interactions.
    Seiden LS; MacPhail RC; Oglesby MW
    Fed Proc; 1975 Aug; 34(9):1823-31. PubMed ID: 1097267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Learning impairment in rats after 6-hydroxydopamine-induced depletion of brain catecholamines.
    Mason ST; Iverson SD
    Nature; 1974 Apr; 248(5450):697-8. PubMed ID: 4151498
    [No Abstract]   [Full Text] [Related]  

  • 12. Operant behavioural and neurochemical effects after neonatal 6-hydroxydopamine treatment.
    Peterson DW; Laverty R
    Psychopharmacology (Berl); 1976 Oct; 50(1):55-60. PubMed ID: 13445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of neonatal and adult 6-hydroxydopamine treatment on random-interval behavior.
    Levine TE; Erinoff L; Dregits DP; Seiden LS
    Pharmacol Biochem Behav; 1980 Feb; 12(2):281-5. PubMed ID: 7375490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of circadian rhythms in brain and organ contents of norepinephrine: circadian changes in the effects of methyltyrosine and 6-hydroxydopamine.
    Lew GM; Quay WB
    Comp Gen Pharmacol; 1973 Dec; 4(16):375-81. PubMed ID: 4788787
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments.
    Cooper BR; Grant LD; Breese GR
    Psychopharmacologia; 1973 Jul; 31(2):95-109. PubMed ID: 4722209
    [No Abstract]   [Full Text] [Related]  

  • 16. Impaired acquisition of an operant response in young rats depleted of brain dopamine in neonatal life.
    Heffner TG; Seiden LS
    Psychopharmacology (Berl); 1983; 79(2-3):115-9. PubMed ID: 6405418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary-adrenal activity and depletion of brain catecholamines after central administration of 6-hydroxydopamine.
    Kaplanski J; Smelik PG
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):263-71. PubMed ID: 4699470
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR; Breese GR; Grant LD; Howard JL
    J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of central catecholamine alterations by 6-hydroxydopamine on shuttle box avoidance acquistion.
    Cooper BR; Breese GR; Howard JL; Grant LD
    Physiol Behav; 1972; 9(5):727-31. PubMed ID: 4655165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.